A clinical study to evaluate the efficacy of Mahamasha Tail Nasya and Valuka Sweda with Vatagajankush Rasa in the treatment of manyastambh (cervical spondylosis).

A comparative clinical study to evaluate the efficacy of Mahamasha Tail Nasya and Valuka Sweda with Vatagajankush Rasa in the management of manyastambh (cervical spondylosis).

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051837

Enrollment

Registered

2023-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having atleast 2 clinical sign and symptoms of Manyastambh (Cervical Spondylosis) with or without radiological changes i.e. Shoola (pain) Stambh (stiffness) Gaurav (Heaviness) Chimchimayan (Numbness) Sparshasahatva (Tenderness) 2. Patients above 21 years and below 70 years. 3. Patients of either sex.

Exclusion criteria

Exclusion criteria: 1. Cervical vertebra fracture 2. Recent cervical, spinal, or shoulder surgery or implanted instrumentation or previous surgery for cervical spondylotic myelopathy. 3. Myofascial pain 4. Cervical rib syndrome 5. Cervical canal stenosis 6. Congenital torticollis 7. Patients suffering from any infectious disease (like tuberculosis), metabolic disease (like diabetes mellitus and hypothyroidism), chronic diseases (like rheumatoid arthritis, SLE, ankylosing spondylitis). 8. Pregnant and lactating mothers. 9. Contraindication and allergy to any drug in Vatagajankush rasa and Mahamasha tail.

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms of manyastambh (Cervical Spondylosis): Shoola (pain) Stambh (stiffness) Gaurav (Heaviness) Chimchimayan (Numbness) Sparshasahatva (Tenderness)Timepoint: DAY-0, DAY-14, DAY-28	—

Secondary

Measure	Time frame
ï?· Improvement in the quality of life in manyastambh patients. ï?· Improvement in the values of Range of Motion and Neck Disability Index.Timepoint: DAY-0, DAY-14, DAY-28	—

Countries

India

Contacts

Public ContactDr Raja Ram Mahto

All India Institute of Ayurveda, New Delhi.

jonahdr@gmail.com9448262298

Outcome results